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3Abstract
Palladium and platinum complexes of pyridoxamine, pyridoxine and
pyridoxal have been prepared. The structures of the complexes
+z-PtClzPM,HZO, t:ranE;~.-PdClZ(PN)Z and [PLH ]Z[PtCl6] .HZO have been determined
by use of single crystal x.....ray studies 4} The compounds PdClZP~l,
by use of carbon-!3 nmr spectroscopy.
PdCIZ(PL)2 were also studied
the complexes have also been
characterised by use of infrared spectral studies.
In the complexes, PtClzPM~HZO and PdClZPM, the ligand pyridoxamine is
chelated to the metal through the aminomethyl nitrogen and the phenolate
oxygen atoms whereas in the complexes, trans-PdClZ(PN)Z' cis-PdClZ(PN)Z
and ~is-PdClZ(PL)2 the vitamin B6 ligands are coordinated to the metal
+ 2-through the pyridine ring nitrogen The compounds [PLH ]2[PtC16 ] .H20
and [PMH2]2+[PdCl4]2-.H2(}-haVe no direct metal-ligand bonding. In all
the complexes, the metal maintains a square coordination except
+ 2-in [PLH ]Z[PtCl6 ] .H20 where the metal is octahedrally coordinated.
PM pyridoxamine
[PMH2]2+ = diprotonated pyridoxamine
PN = pyridoxine
pyridoxal
protonated pyridoxal
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Chapter I
INTRODUCTION
History and structures of vitamin B6
The role of vitamins in the nutrition and metabolic processes of man
has long been discovered since the olden days when sailors on long voyages
reportedly developed scurvy. However,it was not until 1934 that vitamin
B 8. d f8 d 16 actlvlty was e lne •
rats, vitamin B6 was regarded as that part of the vitamin B-complex
responsible for the cure of a specific dermatitis developed by rats on a
vitamin free diet supplemented with vitamin Bl and lactoflavin.
Vitamins are necessary for the normal health and development of the
animal organism and also for bacteria and other microorganisms. Symptoms
of vitamin deficiency result from partial failure of one or more metabolic
functions for which the missing vitamin is essential. The general
characteristics of vitamin B6 deficiency in animals include retarded growth,
acrodynia, anemia, epile?tiform convulsions and partial alopecia.
Deficiency of pyridoxine results in a decrease in serum protein synthesis.
Much nutritional evidence indicates that vitamin B6 is in some way
concerned with fat metabolism. Vitamin B6 deficient animals show a lower
capacity to transform protein into fat and also decrease in the storage of
liver cholesterol. 2 Certain strains of bacteria and yeasts have been
3
reported to grow on one or more forms of vitamin B6 as the sale or
predominant source of carbon and nitrogen.
11
By the middle of 1938, pyridoxine was isolated from rice bran,4 riceS
6
and yeast. With the isolation of pyridoxine achieved, a complete structure
determination was effected. 7 The first synthesis of the vitamin was then
8 910
undertaken. " Later, an improved method of synthesis was carried out
11 . 12 13by Jones and Kornfield. Several other syntheses have been descrlbed. '
Snell14 and his group in the course of their studies of the effects of
pyridoxine on microorganisms discovered pyridoxine-like substances with
even greater growth-promoting activity than pyridoxine. These were the
corresponding aldehyde, pyridoxal and amine" pyridoxamine. From later work
ISby Snell and his group, it was established that the main metabolically
active form of the vitamin B6 compounds is pyridoxal-S-phosphate, also
known as codecarboxylase. However, pyridoxamine.....S-phosphate is also an
.. f" 16lmportant coenzyme or transamlnases. The structures of the vitamin B6
and their phosphate derivatives are shown in Figure 1. It has been
observed that animals respond to all three vitamins. The same situation
must.exists in many fungi and bacteria vitamin B6
exist mechanisms for interconverting the three derivatives. Figure 2
represents the metabolic interrelationship of vitamin B6 in animal tissue
as suggested by 17and Snell.
Pyridoxal, pyridoxamine and pyridoxine are naturally occurring free
forms of vitamin B6 f1 The vitamin also occurs naturally as pyridoxamine-
S-ph-osphate and pyridoxal-5-phosphate.. Pyridoxine is less abundant in
most tissues than the other forms of vitamin B6 •
12
Figure 1. Vitamin B6 and phosphate derivatives.
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Figure 2. The metabolic interrelationship of vitamin B6 in animal tissues
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The vitamin B6 compounds in neutral aqueous solutions have been found
h -b 8 8 18,19,20 Al h h 8 h 1 8 h d 8 1to ex 1 lt tautomerlsm. t aug ln suc so utlons t e lpO ar
ionic forms predominate, a significant amount of the unchar.ged forms also
In alcoholic solution the uncharged form predominates. 19
l3C nmr spectra of the vitamin B6 compounds in aqueous solution. indicate
that the ionization of the pyridinium and phenolic groups take place in
well separated steps and that the compounds exist as zwitterions in neutral
1 8 21aqueoussoutlon. In neutral solid, pyridoxamine exists as the dipolar
22ionic form with the amine nitrogen protonated. Pyridoxine, however,
exists as the uncharged species. 23 X-ray single crystal studies24 and
25infrared spectrum of PMHCl have shown that the pyridoxamine cations
PMH+ have a deprotonated phenolic group and protonated ring and amino
nitrogen atoms. Figures 3 and 4 show the tautomeric forms of pyridoxine
and pyridoxamine respectively. The acid strength of the phenolic group
has been found to follow the order pyridoxamine > pyridoxamine-5-phosphate
> pyridoxal-S-phosphate > pyridoxal> pyridoxine, while the base strength
for the heterocyclic ring~'~,ni·trogenatomfollows' the inverse order 26
The vitamin B6 compounds are involved in a number of extremely
importantmetabolic reactions of the a .....amino acids. Pyridoxal-5-phosphate,
thebiocatalytically active or coenzyme form of vitamin B6 functions in
non-oxidative enzymatic transformations of amino acids and catalyzes such
• 8 • 27,28,29,30 b · °d d kreactlons as transamlnatlon . etween a-amlno aCl s an a- eto
° d 8 8 31,32 f ° 8 d d b 1 8 23aCl s, racemlzatlon 0 a-amlno aCl s, ecar oxy atlon,
Q 1 8 8 8 33,34 d 1 8 8 8 33,35~-e lmlnatlon an y-e lmlnatlon. The enzymatic transamination
15
Figure 3. Tautomeric forms of pyridoxine.
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Figure 4. Tautomeric forms of pyridoxamine.
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reaction between an a-amino acid and an a-keto acid catalyzed by
pyridoxal phosphate has been well studied. These studies led Snel133
and coworkers to propose a mechanism for the reaction. It involves a
reaction of the aldehyde function of the vitamin and the amino group of
the amino acid to form a Schiff base as an intermediate. It has been
observed35 that pyridoxal-5-phosphate catalyzed the transamination of
a-amino acids in the presence of metal ions such as Cu(II), Fe(III),
Al(III), and in the absence of enzymes. On the basis of these observations,
non-enzymatic transamination of a-amino acids by pyridoxal-5-phosphate
was visualised as proceeding through the formation of the metal chelate
containing the Schiff base. Some other typical enzymatic amino acid
transformations have been reproduced in non-enzymatic systems. These
include the decarboxylation and racemization reactions. Because the
non-enzymatic reactions parallel the enzymatic reactions closely, it has
been suggested that both reactions proceed through the same mechanfs.m.
The non-enzymatic reactions have thus become suitable model reactions for
th · t·d f h t- - 37e s u y 0 t e enzyma ~f.reactlons. Figure 5 shows the general
mechanism for the formation of the Schiff base-metal complex.
According to the mechanism, a Schiff base is initially formed from
pyridoxal-S-phosphate and the a-amino acid. The Schiff base is stabilised
by chelating to the metal. The reaction that follows depends on the
ability of the electron attracting groups in the chelated complex to
withdraw electrons from the region of the a-carbon of the amino acid. The
imines derived from the amino acids are prone to cleavage of one of three
18
Figure 5. General mechanism for the formation of Schiff base-metal complex.
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bonds to the a-carbon since the conjugated pyridine system acts as an
electron sink. In the enzymatic reactions, a key function of the enzyme
is to orient the bond to be broken in the substrate......cofactor complex
perpendicular to the plane of the extended conjugated system. If an enzyme
orients the amino acid-pyridoxal-S-phosphate or Schiff base complex such
that the carboxyl group is perpendicular to the conjugated system,
stereoelectronic effects favour decarboxylation. Recent model studies38
show that in the non-enzymatic reactions, the rate of racemization and
hydrogen exchange at the a-carbon of the amino acid-pyridoxal-S .....phosphate
Schiff base is determined by the proportion of conformer having the C -H
a a,
bond orthogonal to the TI-system. Such stereoelectronic requirements enable
pyridoxal-5-phosphate dependent enzymes to enhance reaction rates and
control specificity of bond cleavage by proper conformation orientations.
In the pyridoxal.....5-phosphate catalyzed enzymatic reaction, reactions seem
to occur predominantly o~ only one side of the enzyme.....bound substrate
39
cofactor complex. Figures 6 and 7 show the transamination and
decarboxylation processes.t--respectively in the non-enzymatic reactions It
The catalytic roles of the metal ions in the non-enzymatic reactions
40
were first suggested by Longenecker and Snell as follows
(i) the metal ion maintains the planarity of the Schiff base molecule
to facilitate the electron displacement process,
(ii) the metal ion reinforces the displacement of electrons toward the
pyridine nitrogen,
(iii) the metal ion acts as a template and thus helps in the formation
20
Figure 6. Pyridoxal-5-phosphate in transamination.
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Figure 7. Pyridoxal~5-phosphatein decarboxylation.
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of the Schiff base,
(iv) by stabilizing the intermediate the metal ion can promote
hydrolysis of the Schiff base.
Since the Schiff base ligand is tridentate, complexes with 2:1 and
1:1 ligand:metal stoichiometry can be formed. 41Crystal structures of the
hydrated complexes, bis(pyridoxy1idene-DL-valinato)nickel (II) and
bis(pyridoxylidene-L-valinate)zinc (II) show that both compounds consist
of discrete molecules with octahedral metal ions bonded to two tridentate
Schiff bases. The structure of the Cu(II)-pyridoxylidene complex
Cu(pyr-DL-val)42 also indicates that the Schiff base is tridentate and
planar.
For many of the reactions involving pyridoxal-5-phosphate, Cu(II) has
been found to be much more effective catalyst than Co(1I), Ni(II), 2n(1I),
Fe(II) or Al(III). The order of catalytic activity as established by
40Longenecker and Snell is Cu(1I) > Al(III) > Fe(II) > Fe(III) > Zn(II)
> Ni(II) > Go(II). A small catalytic activity was observed for the series
Cd(II) > Cr(I1) > Mn(II) -'>"Mg(II)
,Bin~ing of Metal Ions to th~ B6 y~tamins.
Studies of the binding of metal ions with vitaminB6 compounds in the
absence of amino acids are of particular interest. Since the vitamin B6
compounds exist in solution as tautomers, chelation to the metal ion depends
very much on the pH of the solution or the predominant form of the tautomer
present. The compounds of vitamin B6 may act either as unidentate ligands
23
and bind the metal ion through the pyridine nitrogen or as a bidentate
ligand and chelate the metal ion by the phenolate oxygen and the nitrogen
or oxygen at the adjacent group in the 4'-position. There is also the
possibility of unidentate binding through the phenolate oxygen. Stability
constant determinations43 of Cu(II) and Ni(II) complexes with pyridoxal
gave values which were of comparable magnitude with those of Cu(II) and
Ni(II) complexes with pyridine, picoline and 3-hydroxy-methylpyridine.
This led to the conclusion that pyridoxal acts as a monodentate ligand
and that the heterocyclic ring nitrogen atom was the ligand atom. A later
44
study of the complex equilibria of Mn (II).~ Ni (II) and Co (II) with
pyridoxine and pyridoxal led to the assumption that pyridoxine and pyridoxal
make use of the meta-oxy atom in the formation of the complexes.
There is little doubt about the liganding sites in pyridoxamine. As
the amino methyl group in pyridoxamine is much more basic than the
hydroxymethyl and hydrated aldehyde groups in pyridoxine and pyridoxal
respectively, pyridoxamine forms much more stable chelate ring structures
than the other ligands. -However, a polarographic determination of the
stability constants45 of Cd(II) and Zn(II) complexes with pyridoxamine gave
results which imply that pyridoxamine can act as a monodentate ligand and
coordinate 2n(II) through the heterocyclic nitrogen atom. The study did
not exclude the possibility that the ligand may chelate 2n(II) through the
meta-oxy group and the nitrogen atom of the amino group, but in such
case mixed monodentate and bidentate complexation of the ligand to 2n(II)
may occur.
24
46The crystal structure of a pyridoxamine complex of Zn(II),
[Zn(PM)2(H20)2] (N03)2 shows that the zinc atom lies on a center of symmetry
and is chelated to the aminomethyl nitrogen and the phenolate oxygen of
ed e e e R 1 47,48 d· f d25pyrloxamlne zWltterlon.ecent crysta structure an ln rare
studies of copper complexes of anionic and neutral pyridoxamine show that
the copper atoms are chelated to the pyridoxamine ligand through the
(aminomethyl) and the phenolate groups of a pyridoxamine zwitterion.
Complexes of pyridoxal-S-phosphate and pyridoxamine-5-phosphate with
49Cu(II), Co(II) and Zn(II) have been prepared by Farago et ale Their study
indicates no case of the pyridine nitrogen involved in coordination.
Nuclear magnetic resonance studies50 using 3lp , lH and l3C of the pyridoxal-
PLP in
which the metal ion is simultaneously bound to the phosphate and the
aldehyde oxygens.
The liganding site in pyridoxine seems to depend on the type of solvent
medium used, A 13C nmr study has shown that coordination of the metal ions
by pyridoxine is through_~b~phenolicoxygen and the oxygen at the adjacent
group in the 4'-position in aqueous solution. In water-dimethylsulfoxide
mixture, the pyridine nitrogen becomes a more effective donor and with
increasing proportions of dimethylsulfoxide some cations are coordinated
by dimethylsulfoxide rather than pyridoxine,5l Single crystal x-ray
structure and l3C nmr (D20) studies
52
of Cd(PN)C12 indicate
that the pyridoxine molecule is,bidentate and chelated to the cation through
the phenolic oxygen and the oxygen at the adjacent hydroxymethyl group.
25
Goals of the Research
Even though there is sufficient evidence for the occurrence·<'of a
monodentate coordination of the heterocyclic nitrogen atom to the cation in
solution, such complexes have not yet been isolated in the cyrstalline
form. Synthesis of such complexes in the crystalline form would be a
tremendous step towards the elucidation of their crystal and molecular
structures. Such structures could be compared to the normal chelated ones
to see what effect the various coordination sites have upon the ligand
structure. It would also be interesting to know what effect the heterocyclic
nitrogen-metal bond will have on electron displacement process from the
a-carbon of the Schiff base intermediates.
In this work, palladium and platinum complexes of pyridoxine, pyridoxal
and pyridoxamine and their acid forms have been synthesized. Infrared,
l3C nmr and single crystal x-ray diffractometry studies have been done on
some of the complexes obtained. It is interesting to note that for the
first time, a metal-pyridoxine complex has been obtained in the crystalline
form in which the ligand -~is ~'monodentate and the heterocyclic nitrogen atom
is coordinated to the metal.
26
Chapter II
EXPERIMENTAL
CHEMICALS:
Potassium tetrachloropalladate, K2PdC14 , and potassium tetrachloro-
platinate, K2PtC14 were purchased from Alfa Products. Palladium(II)
chloride, PdClZ,was obtained from Matheson, Coleman and Bell. Pyridoxal
hydrochloride, pyridoxamine dihydrochloride and pyridoxal-5-phosphate
were purchased from Sigma Chemicals. Pyridoxine hydrochloride was
purchased from Eastman Kodak Company.
All reagents were used without further purification.
INSTRUMENTATION:
-1 -1Infrared spectra in the 4000 cm to 200 cm range were recorded on
a Perkin-Elmer 225 grating infrared spectrophotometer. The samples were
prepared as mulls in Nujo1:; .- Potassium bromide discs and caesium iodide
-1 -1discs were used to record spectra in the range 4000 em to 600 cm and
-1 -1600 cm to 200 em respectively. The spectra were calibrated with
polystyrene and the peaks were measured from the chart. 13C nuclear
magnetic resonance spectra were obtained at 15.08 MHz on a Bruker WP-60
FT NMR spectrometer at a temperature of 300 0 K and flip angle of 30° using
0.5 Hz of line broadening. A sweep width of 3759 Hz and a 1.1 second
acquisition time were used. Samples were prepared in DMSO-d6 - The internal
standard was either TMS orDMSO. The number of scans varied from 2000 to
32000.
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Oscillation photographs were taken on a Picker X-ray generating
instrument using a Weissenberg camera from Charles Supper Company and
No-screen medical x-ray films from Kodak. The films were exposed for about
20 minutes to CuK radiation (A = 1.542 A). The Weissenberg photographs
a
were taken using nickel filtered CuK radiation with exposure times of
a
12-24 hours. The photographs were indexed and approximate unit cell
dimensions and space group were obtained by following the procedures
outlined in Stout and Jensen. 53 The crystals were then transferred to a
CAD-4 diffractometer and the structures were determined by Professor M. F.
Richardson.
ELEMENTAL ANALYSIS:
Elemental analyses were done by Galbraith Laboratories Inc.,
Knoxville, Tennessee and Guelph Chemical Laboratories, Guelph, Ontario,
and Mikronanalytisches Laboratorium, Bonn, Germany. The analyt-ica1 results
are shown in Table 1.
SYNTHESIS OF COMPOUNDS:
Neutral pyridoxamine, pyridoxine and pyridoxal were prepared by adding
aqueous sodium hydroxide solution to the aqueous solutions of the acid
forms of the ligands until the pH was between 7 and 8. The precipitated
crystals were filtered and washed with water. They were recrystallised in
water.
Table 1. Analytical Data
Compound Found
C H N Cl
Calculated
Metal C H N Cl Metal
PdC1ZltPM
C8HIZNZOZPdCIZ
PtC1Z·PM.HZO
CSH14NZ03PtClZ
PdC1Z e (PL)2
C16H1SNZ06PdC1Z
Z7.60 3.74 7.72 19.91
2l.2~ 3.11 6.20 16.32
37.39 4~23 5.43
27.S0 3.50 S.10 20.60
21.24 3.10 6.19 15.71
37.54 3.52 5.48 N
00
tra~s-PdC1Z(PN)Z
C16H22NZ06PdC12
ci~-PdCIZ(PN)2
C16H22N206PdC12
2+ 2-[PMH2] [PdC14 ] .H20
CSH16N203PdC14
+ Z-[PLH ]2[PtC16 ] .2H20
C16HZ6N209PtC16
36.90 4.44 5.40 12.89 37.23 4.27 5.43 13.77
37.47 4.49 5.57 37 23 4.27 5~43 13.77
Zl.93 3.79 6.38 3Z.40 23.10 22.02 3.67 6.42 32.57 Z4.30
24.34 3.17 3.45 25.74 22.76 24.62 3.0S 3.59 27.30 25.00
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Synth~sisof PdClZePM
K2PdC14 (0.5 g) was dissolved in water (20 roL). PM.ZHZO (0.3 g) was
dissolved in warm water (20 mL) and then added to the Pd solution while
stirring. A few drops of 0.1 M NaOH s,olution were added until the pH ~ 7.
The yellow precipitate produced was filtered, washed with water and ethanol.
The product was air dried. Several attempts were made to recrystallise the
product in various solvents but no crystals were produced. The'yellow
powder was always obtained. The same yellow powder was obtained at pH 8-9.
PdClZePM c~ystals grown in gel
The gel was formed by titrating 0.5 M NaOH with a 0.5 M sodium
metasilicate solution to a pH of 7.5. A solution of K2PdC14 (0.2 g) in
water (20 roL) was then added and stirred to ensure thorough mixing. The
resulting solution was placed into 50 mL test tubes and allowed to set
About 20 mL of solution was placed in each test tube. The gel set in about
30 minutes.
PM.2HZO (0.15 g) was dissolved in warm water (ZO mL). The solution
was allowed to cool to room temperature. Five mL of the PM.ZHZO solution
was carefully added to each tube without damaging the gel at the interface.
The tubes were lightly stoppered and placed in a closed cupboard. Yellow
crystals up to 3 rom in length were produced by the end of two weeks.
30
2+ 2-Synthesis of [PMH2] [~~C14]_ .H20
PdC12 (0.1 g) was added to 0.1 M HCl (10 mL) and benzene (10 mL)
The mixture was stirred until all the PdCl2 dissolved. P:tvf (0 g) was then
added, and stirring continued for two hours. The resulting clear solution
was kept in the fume hood to concentrate Large yellowish-brown needlelike
c~ystals developed. The crystals were filtered, washed with water and
finally with acetone and air dried.
_Synthesis of PtC12 .PM.H20
K2PtCl4 (0.25 g) was dissolved in water (10 mL). PM.2HZO (0.25 g) was
dissolved in warm water (30 mL) and allowed to cool to room temperature.
The PM.2H20 solution was added in drops to the Pt solution while stirring.
The pH was brought to 7 by addition of a few drops of NaOH solution. The
resulting solution was stirred for 15 minutes and then kept in a closed
cupboard to ensure slow evaporation. Yellow needlelike crystals were
obtained after -2-3 The crystals were filtered and washed with water
followed by ethanol and a±r 'dried.
+. 2-Synthesis of [PLH ]2[PtC~6] .H20
K2PtCl4 (0.5 g) and PLHCI (0.5 g) were added to water (30 mL). The
mixture was heated while stirring for about 10 minutes. The resulting
solution was allowed to cool and then filtered. The filtrate was kept in
the fume hood to evaporate. Orange platelike crystals formed after a day.
The crystals were filtered and washed with water and allowed to dry in air.
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Synthesis of trans-PdClZ(PN)Z
K2PdC14 (D.3 g) was dissolved in water (2D mL). PN (0.4 g) was
dissolved in water (2D mL) and then added in drops to the Pd solution while
stirring. The pH of the solution was adjusted to 7 by carefully adding a
few drops of NaOH solution. The resulting solution was kept in a closed
cupboard to ensure slow evaporation. Small yellow needlelike crystals
developed after a day. The crystals were filtered and washed with water
and air dried.
There is an immediate precipitation of yellow powder compound if the
pH is slightly above 7. At high pH, the precipitate dissolves. Such
solutions never produced crystals, but rather gave a thick yellow paste
Synthesis of.cis-PdClZ(PN)2
K2PdCl4 (0.8 g) was dissolved in water (20 mL). PN (0.6 g) was
dissolved in water (15 mL). The PN solution was then added in drops to the
Pd solution while stirring. The pH of the resulting solution was 6. The
solution was left in a close"d cupboard to evaporate. Yellow platelike
parallelepiped crystals were obtained after a day. The crystals were
filtered and washed with water, and finally with ethanol. They were air
dried.
Synthe?~sof cis-~dCI2(PL)2
K2PdCl4 (0.4 g) was dissolved in water (20 mL). PL (0.4 g) was
dissolved in warm water (20 mL). The PL solution was allowed to cool to
room temperature and then added dropwise to the palladate solution while
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stirring. A few drops of NaOH solution were added until the pH was 7,
whereupon a yellow precipitate appeared. Stirring was continued for 10
minutes and the precipitate was filtered, washed with water followed by
ethanol and then air dried.
Attempts were made to grow crystals of the above product from gel as
described in the synthesis of PdCl2PM, but that resulted in bundles of
minute crystals unsuitable for single crystal x-ray studies.
Attempted reacti()n of K2PtCl4 withPyridoxine
IZZPtC14 (0.25 g) was dissolved in water (10 mL). An aqueous solution
of PN (0.2 g in 10 mL water) was added in drops to the platinate solution
while stirring. The pH was adjusted to 7 by addition of a few drops of
0.1 N NaOH solution. The resulting solution was stirred for about 30
minutes, and then kept in a cupboard to ensure slow evaporation
Red needlelike crystals developed after 2 days. An infrared spectrum
indicate~ that the crystals are K2PtCl4 8
A second attempt wag-made by refluxing the solution for 30 minutes,
but PtO deposited during and after refluxing. Other attempts under
various pH conditions and in different solvents yielded no good results.
AttemEted reactions of CPt (H2,2.l..q) 2+ with vitamin B6
A solution of [Pt(H20)4]2+ in 1 N HCI04 was prepared as reported by
Okeya and Kawaguchi- 54 Portions of the [Pt(H20)4]2+ solution were treated
separately with equimolar amounts of pyridoXine, pyridoxal, pyridoxal-5-
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phosphate and pyridoxamine. The solutions were stirred for 30 minutes and
then kept in the fume hood to evaporate. White crystals separated out from
the orange-yellow solution. The crystals were filtered and washed with
water, and dried in air. The infrared spectra indicate the formation of
the acid forms of the ligands.
New reaction mixtures were prepared and attempts made to:neutralise
the solutions by addition of aqueous NaOH solution. It was not possible
to raise the pH above 3. PtO precipitated out of the solution when NaOH
solution was added.
Reactions of vitamin B6 with [Pd(dien)HZO](Cl041z
(a) Synthesis of PdIzoHZO
A solution of KZPdC14 (1.5 g) in water (40 mL) was heated to about
90°C. Excess KI was added to precipitate virtually insoluble PdIzeHzO
which was filtered, washed with water and dried in air.
(b) Synthesis of [Pd(dienJI]I
A few drops of water was added to PdIZ~l-IZO (1.6 g) to form a thick
paste. About 0.2 mL of dien was added in dropwise with stirring. The
resultant mixture was baked to dryness on a steam bath. The solid was
extracted with water at 90°C. The unreacted PdIzoHZO was separated by
filtration and the yellow filtrate was evaporated on a steam bath until
crystals appeared. The solution was cooled to 5°C and the crystalline
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product was filtered, washed with water and dried in air. The infrared
55
spectrum of the product was the same as reported by Watt and Klett.
(c) Synthesis of [Pd(dien)H20](Cl04)2
A suspension of [Pd(dien)I]I (0.8 g) in water (10 mL) was treated with
AgCl04 (0.72 g). A rapid precipitation of AgI occurred. The solution was
heated for about 12 minutes on a boiling water bath to ensure complete
reaction before filtering off the AgI precipitate. The precipitate was
washed with about 20 mL of hot water and the combined filtrate was
concentrated to 10 mL on a boiling water bath.
(d) Attempted synthesis of [Pd(dien)vitB6](Cl04)Z
The [Pd(dien)HZO] (Cl04)2 solution obtained in (c) was divided into
three equal portions. Equimolar amounts of solutions of pyridoxal,
pyridoxine and pyridoxamine were added separately to the three solutions.
Each resultant solution was stirred vigorously for one hour and then left
in the fume hood to evaporate. The vitamin B6 compounds separated out
from the yellow solution. More vigorous conditions such as prolonged
stirring and heating on boiling water bath produced no complexation.
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Chapter III
RESULTS AND DISCUSSION
Synthesis:
The vitamin B6 compounds were reacted with the palladium and platinum
chlorides under different pH conditions. In very acidic conditions,
pH = 2, pyridoxamine reacted with the palladium to form brown needlelike
crystals. Results of the elemental analysis, shown in Table indicate
2+ .2- ..
that the compound has the molecular formula [PMHZ] [PdC14 ] .H20. It looks
probable from the formula that there is no direct metal-pyridoxamine bonding
The cation [PMHz]z+ is formed in acidic medium with both the pyridine and
the amino nitrogens protonated. Under such conditions, the cation [PMHZlz+
formed the salt with the tetrachloropalladate anion [PdC14]Z-. The salt
crystallises out of solution with a molecule of water. At neutral pH, the
reaction between pyridoxamine and potassium tetrachloropal1adate results
in an immediate precipitat.ion of yellow powdered compound. The elemental
analysis shows that the yellow powder has the molecular formula PdCIZPM.
Under similar conditions, the reaction between pyridoxamine and potassium
tetrachloroplatinateproduced yellow needlelike crystals after two days.
The elemental analysis gave the formula PtClZPM.HZO. At pH between 8 and
9, the same yellow powdered compound was obtained in the reaction of
pyridoxamine and potassium tetrachloropalladate, but in the case of
potassium tetrachloroplatinate, no precipitate could be isolated when the
reaction was carried out at a pH between 8 and 9.
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The reaction of pyridoxine with potassium tetrachloropalladate produced
some interesting results. At neutral pH, the reaction yielded yellow small
needlelike crystals after one day. The elemental analysis gave the
molecular formula PdCl2 (PN)2- There was an immediate precipitation of
yellow powdered compound when the pH was slightly above 7~ The infrared
spectrum of the powder was the same as that of the yellow needlelike
crystals, therefore the powder was not submitted for elemental analysis
since it was thought to be the same as the crystalline product obtained at
pH 7. At pH above 8, there was no product isolated. The solution on
standing fQ~med a thick yellow paste. At pH 6, pyridoxine reacted with the
palladate to form yellow platelike crystals. When the crystals were
examined under the microscope, they were observed to be flat parallele-
pipeds with well defined edges. However, the elemental analysis gave the
molecular formula PdC12(PN)2 which is the same as that obtained for the
needlelike ,crystals obtained at pH 7.
The reaction of pyridoxine with potassium tetrachloroplatinate under
similar conditions as useil.for the palladate and also under more vigorous
conditions produced no analogous products. In most cases, the potassium
tetrachloroplatinate crystallised out of solution.
Pyridoxal reacted with potassium tetrachloropalladate to produce a
yellow complex which precipitates out of solution immediately at pH 7. The
elemental analysis indicates that the complex has the molecular formula
PdC12 (PL)2- A mixture of solutions of pyridoxal and potassium tetrachloro-
platinate at pH 7-8 on standing overnight, deposited a brown-yellow powder.
The product was thought not to be pure, so no elemental analyses were
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performed. The infrared spectrum of this product showed a strong band
-1
at 1770 em Some attempts were made to a purer product
from this reaction, but with no success. At pH 3-4, pyridoxal formed
orange platelike crystals with the platinate after a day. The elemental
+ 2--
analysis gave the molecular formula [PLH ]Z[PtC16] .HZO.
Pyridoxal-5-phosphate produced no complexes with the palladate and
the platinate under the reaction conditions employed. The reaction of
potassium tetrachloropalladate with pyridoxal-5-phosphate at pH 7 produced
greenish needlelike crystals. However, the infrared spectrum of the product
did not indicate the presence of pyridoxal-5-phosphate. The product turned
out to be the pal1adate which crystallised out of solution. Similarly,
the platinate crystallised out of solution without forming a complex with
the ligand.
Various other methods were employed with the aim of producing complexes
that might have the pyridine ring nitrogen of the vitamin B6 compounds
d~rectly bonded to the metal. It was thought that by blocking three of the
liganding sites in square~-planar Pd(II) or Pt(II) with a strong tridentate
chelating ligand as diethylenetriamine, and occupying the fourth site with
a solvent that forms a relatively weak bond to the metal, it might be
possible for the vitamin B6 ligands to substitute the weakly bonded solvent
by forming a monodentate bond to the metal. The diethylenetriamine
palladium(II)-aquo complex used did not produce a complex with any of the
vitamin B6 ligands under the reaction conditions employed. The vitamin B6
Z+
compounds were also unreactive towards [Pt(HZO)4 l '. The reactions of
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[Pt(H20)4]2+ with the vitamin B6 compounds were carried out in very strong
acidic medium in which case all the liganding sites of the vitamin B6
compounds were protonated. This resulted in the acid forms of the
vitamin B6 compounds crystallising out from the solution. Attempts to
neutralise the acid solutions resulted in precipitation of PtO.
Crystallographic study of the complexes
The crystal data for the compounds ~ra~s-PdCl2(PN)2' PtClZPM.H20 and
+ Z-[PLH ]Z[PtC16] .H20 are shown in Table 2.
t~ans....PdCl2<PN)<2: The single crystal x-ray study shows that the
pyridoxine ligands are directly bonded to the metal atom through the
heterocyclic ring nitrogen. The molecules lie on centres of symmetry. The
Pd atoms are square planar with the two chlorine atoms trans to each other.
The structure is shown in Figure 8. The bond distances and angles in
trans ....PdClZ(PN)2 are shown in Tables 3 and 4 respectively. The bond
distances and angles in the free ligand are also shown. The Pd-N bond
distance is 2.030(3) A. -tlark and Palenik56 have observed that the Pd-N
distances found in square planar palladium(II) complexes in which the Pd-N
bond is neither sterically hindered nor .trans to a very strong metal-
ligand bond are in the range 1 99-Z 04 A. The value obtained for
. 57 58trans....PdClZ(PN)2 is within this range and agrees well wlth other '
o
palladium....pyridine nitrogen bond distances tt A bond distance of 1.365(4) A
found for the C(Z)-O(l) bond indicates that the phenolic group is protonated.
o
This value is comparable to that obtained for the free ligand (1.374(4) A)
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Table 2. Crystal Data
2-]~H20
Formula PdC12C16H22N206 PtC16C16H20N206-H20 PtC1zCSH12N202eH20
M W. .40 760.40 452.10
Crystal System monoclinic tric1inic orthorhombic
a (A) 5.271(2) 7@355(2) 7.028(1)
b (A) 17.263(2) 8.534(2) 12 788(1)
°c (A) 10.269(1) 11.555(2) 13.435(2)
a. (0) 90.00 71.73(2) 90.00
f3 (0) 95.41(2) 73.10(2) 90.00
y (0) 90.00 66.79(2) 90.00
V (13) 930.25 621.26 1207.46
Space group P21 /c pI P212121
dobs
3 1.78 2.025 2.46(g/cm )
3 1.84 2.032 2.49dca1c(g/cm )
Z 2 1 4
R 0.030 0.059 0.030
l\v 0.034 0,056 0.031
Cell dimensions determined ..from 25 accurately centered
MoKa radiation, on a CAD-4 diffractometer
Figure 8a. Structure of trans-PdC12 (PN)2
Cl
j-Y
z
H
~
o
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Cl
Figure 8b. Structure of trans-PdC12 (PN)2 plotted on projection perpendicular to the PdC12N2 plane.
+:--
I--'
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Table 3. Bond lengths in traI!-s-PdCI2(PN) 2 and in the free ligand
trans~PdC12(PN)2 free ligand23
(X) (X)
C(I)-C(2) 1.406(5) 1.394(5)
C(2)-C(3) 1.382(5) 1.389(5)
C(3)-C(4) 1.407(5) 1.401(5)
C(4)-C(5) 1.385(5) 1.370(5)
C(5)-N 1.335(4) 1 340(5)
N-C(I) 1.347(4) 1 332(4)
C(1)-C(6) 1.489(5) 1.507(5)
C(2)-O(I) 1.365(4) 1.374(4)
C(3)-C(7) 1.514(5) 1.518(5)
C(7)-O(2) 1 426(5) 1.391(5)
C(4)-C(8) 1.511(5) 1.521(5)
C(8)-O(3) 1.429(5) 1 422(4)
Pd-N
Pd-Cl
2.030(3)
2.314(1)
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Table 4. Bond angles in ~rans-PdC12(PN)2 and in the free ligand
~rCln~-PdC12(PN)2 -23free ligand
(0) (0)
C(2)-C(1)-N 119 2(3) 120.8(3)
C(6)-C(1)-C(2) 120.4(3) 120.5(3)
C(6)-C(1)-N 120.3(3) 118.7(3)
C(1)-C(2)-O(I) 115 1(3) 117.3(3)
C(3)-C(2)-O(I) 123.2(3) 122.3(3)
C(3)-C(2)-C(1) 121.6(3) 120 3(3)
C(7)-C(3)-C(2) 123.8(3) 121 8(3)
C(7)-C(3)-C(4) 118.9(3) 120.6(3)
C(5)-C(4)-C(3) 118.7(3) 118.6(3)
C(8)-C(4)-C(3) 122.3(3) 120.3(3)
C(8)-C(4)-C(5) 119 0(3) 121.1(3)
C(3)-C(7)-O(2) 112.2(3) 111.2(3)
C(4)-C(8)-O(3) 109 6(3) 112.2(3)
C(4)-C(5)-N 122.9(3) 123 3(3)
C(4)-C(3)-C(2) 117.3(3) 117.7(3)
C(5)-N-C(1) 120.2(3) 119 3(3)
C(I)-N-Pd 122.2(2)
C(5)-N-Pd 117.6(2)
N-Pd-Cl 90.6(1)
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which was observed23 to have an unionised phenolic group It is, however,
longer than those found in complexes with deprotonated phenolic group as
in CU(PM-H)2.2H20
48
and (pyr-DL-va1inato)Cu(II)59 where values of 1.330(3) A
o
and 1.310(9) A respectively were obtained. The C(5)-N-C(1) bond angle in
tr~ns_-PdGI2(PN)2 is 120.2°. In the free ligand, this angle is 119 3 0 as
d f d -d- · 60 I -d· h dexpecte or a non-protonate pyrl lne rlng. n pyrl OXlne monoy ro-
chloride where the pyridine ring nitrogen is protonated, the C(5)-N-C(1)
61 .
bond angle was found to be 124.7°. Since the pyridine ring nitrogen is
coordinated to the metal in tran~~PdCI2(PN)2' it might be expected that
coordination will lead to the opening of the C(5)-N-C(1) bond angle to a
value comparable to that obtained in PNHCl. It looks as if coordination of
the ring nitrogen atom to the metal had no significant effect on the
C(5)-N-G(1) bond angle. Comparison of the bond distances in the coordinated
and free ligand shows n9 appreciable difference between the two values.
The pyridine ring is capable of n-bonding with the filled d-orbitals
of the central ~ta1 atom62 so that electron deficiency that might h~e
resulted over the ring from .·the pyridine nitrogen-metal bond is replenished
Such a situation will tend to keep the n-electrons delocalised over the
ring system approximately constant The pyridoxine ligand might be capable
of similar back-bonding and therefore offset the effect of the palladium-
pyridine nitrogen bond on the ring. Another possible explanation might
be the effect of the larger size of palladium compared to hydrogen, thus
preventing the opening of the C(5)-N-C(1) bond angle on coordination.
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PtCl2PM.~20: The bond distances and angles are shown in Table 5.
The crystal structure shows that the platinum atom is square planar and is
chelated to pyridoxamine through the phenolate oxygen and the aminomethyl
nitrogen atoms. The pyridine ring nitrogen is protonated. The structure
of the complex is shown in Figure 9. The Pt-O(I) and Pt-N(2) bond distances
are 2 015(4) 1 and 2.031(6) Xrespectively~ Also the Pt-Cl(l) and Pt-Cl(2)
distances are 2.313(2) Aand 2.286(2) Arespectively. These values agree
well with other63 ,64,65 Pt-O, Pt-N and Pt-Cl bond distances. The short
Pt-Cl(2) distance compared with Pt-Cl(l) distance is expected since the
Pt-Cl(2) bond is trans to a stronger metal-oxygen bond. The bond angles
and distances in the coordinated pyridoxamine are similar to those found46 ,48
in the zinc and copper complexes of pyridoxamine
+ 2-[PLH ]2[PtC~6~20: The structure shows that both pyridoxal groups
are protonated at the pyridine ring nitrogen atoms The phenolic groups
are unionised. Each pyridoxal molecule exists in the hemiacetal form. The
bond distances and angles are shown in Table 6 The C(5)-N-C(1) bond angle
is 126.3° as expected fo:t=.o-pFotonated pyridine ring nitrogen. The angle is
higher than that obtained for trans-PdC12 (PN}2' but compares favourably
with values obtained for PNHCl (124.7°) by Bacon and Plant61 and for PMHCl
(125.1°) by Longo and Richardson 24 The platinum is octahedrally coordinated
2- 0in the [PtC16 ] anion with an average Pt-Cl distance of 2 32 A. The Cl(2)
and Cl(2') atoms are hydrogen bonded through N-H of the pyridoxal cations.
+ 2-Figures 10 and 11 show the structures of the [PLH ] and [PtC16 ] groups
+ 2-in [PLH ]2[PtC16] H20.
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Table 5. Bond distances and angles in PtCIZPM.HZO.
° Angle (0)Distance (A)
C(Z)-O(l) 1.342(7) C(5)-N(I)-C(1) 125.2(6)
C(8) ....O(2) 1 444(8) C(2)-C(1)-N(1) 116.4(6)
C(5)-N(1) 1.319(9) C(6)-C(1)-N(I) 121.1(6)
C(l)-N(l) 1.334(8) C(6)-C(1)-C(Z) 122.4(6)
C(7)-N(Z) 1.487(9) C(1)-C(2)-O(1) 112.8(5) .
C(6)-C(1) 1.495(9) C(3)-C(2)-O(1) 126.7(5)
C(1)-C(2) 1.429(8) C(3)-C(2)-C(1) 120.4(6)
C(3)-C(2) 1.407(8) C(4)-C(3)-C(2) 118.8(6)
C(4)-C(3) 1.402(8) C(7)-C(3) ....C(2) 122 1(5)
C(7)-C(3) 1@501(8) C(7)-C(3)-C(4) 119.1(6)
C(4)-C(5) 1.403(9) C(5)-C(4)-C(3) 118.0(6)
C(8)-C(4) 1.490(9) C(8) ....C(4)-C(3) 122.3(6)
C(1)-C(6) 1.495(9) C(8)-C(4)-C(5) 119.7(6)
C(4)-C(5)-N(1) 120.8(6)
Pt-C1(1) 2.313(2) C(3)-C(7)-N(2) 114.Z(5)
Pt....C1(2) 2 286(2) C(4)-C(8)-O(2) 113.3(6)
Pt-O(l) 2.015(4) C(2)-O(1)-Pt 124.9(4)
Pt-N(2) 2.031(6) N(2)-Pt-O(1) 90 9(2)
N(2)-Pt-Cl(2) 90.4(2)
N(2)-Pt-C1(1) 177.8(2)
O(1)-Pt-C1(2) 177.8(2)
O(1)-Pt-C1(1) 86 9(1)
C1(2)-Pt-Cl(1) 91.8(1)
\
\
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Figure 9. Structure of PtC12PM.H20
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- hydrogen bonding
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126.2(6)
118.2(6)
116@9(7)
120.0(7)
121.8(7)
116.4(6)
117.1(6)
103.8(6)
131.1(7)
109.2(6)
111 2(5)
119.7(7)
130 0(6)
108.0(6)
121.9(6)
112.5(6)
110.3(5)
104 1(5)
126.5(5)
C(5)-N-C(1)
C(2)-C(l)-N
C(4) ....C(5)-N
C(6)-C(1)-N
C(6) ....C(1)-C(2)
C(I)-C(2)-O(I)
C(1)-C(2)-C(3)
C(4)-C(8)-O(3)
C(8)-C(4)-C(5)
C(8)-C(4) (3)
C(8)-O(3)-C(7)
C(5)-C(4)-C(3)
C(2)-C(3)-C(7)
C(4) -C (3) -C (7)
C(4)-C(3)-C(2)
O(3)-C(7)-O(2)
C(3)-C(7)-O(2)
C(3)-C(7)-O(3)
C(3)-C(2)-O(1)
2.319(2)
2.322(2)
2.314(2)
+ 2-Bond distances and angles in [PLH ]2[PtC16] .H20
Angle (0)Distance (A)
C(1)-C(2) 1.416(9)
C(2)-C(3) 1.384(8)
C(3)-C(4) 1.387(9)
C(4)-C(5) 1.381(10)
C(5)-N 1.344(11)
N-C(l) 1.334(10)
C(1)-C(6) 1.493(10)
C(2)-O(1) 1.334(8)
C(3)-C(7) 1.517(9)
C(7)-O(2) 1.408(9)
C(7) ....O(3) 1.404(8)
C(4)-C(8) 1.496(10)
C(8) ....O(3) 1.443(10)
Table 6
Pt-C1(1)
P~-C1(2)
Pt.....C1(3)
Cl(2)-Pt-C1(1)
C1(3)-Pt-C1(1)
C1(3)-Pt-C1(2)
90.6(1)
89.4(1)
88.7(1)
Figure 10.
~
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+ + 2-Structure of [PLH ] in [PLH ]2[PtC16] .H20
H
o (1 ) / ..-r ..--",\\\\1
H
I
I
I
+ 2-CL(1) on [PtClh ]
Cl t1 )
Ct { 3:)
Cl (2/)
Cl t3)
V1
o
2- + 2-
Figure 11. Structure of [PtC161 in [PLH 12[PtC161 .H20
Cl l1')
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PdC12P~ and. cis-P4C12.(PL}2 : Crystals of PdCl2PM and cis-PdC12 (PL) 2
were grown in gels. The yellow needlelike crystals obtained for PdCl2PM
were found to have minute crystals on their surfaces and therefore could
not be used for single crystal x-ray studies. In the case of cis-PdC12 (PL)2'
bundles of minute crystals which were unsuitable for crystallographic
studies were obtained from the gel.
Infrared spectra of the ligands:
The vibrational spectra of pyridine, pyridinium ion and substituted
"d" h b 11 d t d 63,64~65,66,67,68pyrl lnesave eenwe ocumen e • By comparison of the
pyridine
spectra of the vitamin B6 ,compounds with those of pyridine, pyridinium ion
and the substituted pyridines, some vibrational frequencies in the
.. . 25 69
vitamin B6 compounds have been asslgned. '
The following paragraphs are meant to point out the major features in
the infrared spectra of the ligands. These features will then be used to
show the possible structures of the complexes.
-1There are four char~~~~ristic bands near 1630, 1610, 1535 and 1485 cm
in the spectra of the pyridine compounds. These peaks are associated with
the ring breathing frequencies. The occurrence of HOH and HNH bending
-1 '
modes of about 1650 and 1600 cm , however, makes the identification of the
peaks at 1630 and 1610 cm-l difficult. The four ring breathing
modes of pyridine and substituted pyridines have been observed to shift to
higher frequencies in pyridinium salts. The ring modes are of variable
intensities and depend on the substituents. The band at about 1535 cm is
present in all the protonated pyridine compounds.
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The infrared spectrum of neutral pyridoxal, Figure 12, has been
discussed by Reinert and Martell. 69 They noted that the c=o stretching
band is absent and attributed this to the occurrence of pyridoxal
predominantly in the hemiacetal form. Three weak and sharp bands between
2100 and 2000 c~l h~e been considered as indication of tha dipolar nature
of the compound in the crystalline state. There is no free O-H band.
Bands at~about 3175, 3090 and 2740 cm-l have been assigned to the chelated
-1O-H and intermolecular O•••H-N bands. The band of 1540 cm suggests that
the pyridine ring nitrogen is protonated. Figure 13 shows the structure
of crystalline pyridoxal as proposed by Reinert and Martel1. 69
The infrared spectrum of pyridoxal monohydrochloride, Figure 14, like
......1
the spectrum of neutral pyridoxa-l, has a strong peak at 1545 cm _ and a
medium peak at 1625 cm The peak at 1545 cm-l indicates that the pyridine
ring nitrogen is protonated. There is no carbonyl stretching peak, and
hence the pyridoxal monohydroch1oride might also exist as the hemiacetal
form. -1The bands between 2100 and 2000 em in the spectrum of the neutral
pyridoxal are absent in t-oo ,spectrum of PLHC1.
There is no strong band between 1600 and 1500 cm-l in the spectrum,
Figure 15, of neutral pyridoxamine. This an indication of the absence
-1
of a protonated pyridine ring nitrogen. There is a weak peak at 1620 em
which could be assigned to a ring breathing frequency or the HNH bending
-1
mode The weak peak at 2080 em shows the presence of a protonated amino
70 -1group. The broad band above 3000 em is due to NH and OH stretching
vibration.
Figure 12. Infrared spectrum of pyridoxal.
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Figure 13. Structure of crystalline pyridoxal (free base).
H~I
Figure 14 Infrared spectrum of pyridoxal monohydrochloride"
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Figure 16 shows the infrared spectrum of pyridoxamine dihydroch1oride.
-1The spectrum exhibits a strong peak at 1535 ern for aprotonated pyridine
nitrogen. There is a weak band at 1760 cm-l which is also present in the
spectrum of the neutral pyridoxamine, but it is hard to say which frequency
this might be attributed to even though it has been observed that the weak
peaks between 2200 and 1700 cm-l could be due to the -NH3+ combination
bands.
The spectrum of neutral pyridoxine, Figure 17, shows no strong peaks
-1 1between 1600 em and 1500 cm- An infrared study by Franklin and
Richardson25 shows that the weak peaks' between 1600 and 1500 em......1 in the
spectra of neutral pyridoxine and pyridoxamine are essentially unchanged in
the spectra of the deuterated compounds, and therefore cannot be attributed
to the presence of a protonated pyridine nitrogen. The absence of a
protonated pyridine nitrogen has been confirmed by single crystal x-ray
d - 23stu l.es.
In contrast to the spectrum of neutral PN, the spectrum of pyridoxine
-1 -1
monohydroch1oride, Figur~-18' shows strong peaks at 1540 cm and 1620 cm •
The presence of a protonated pyridine ring nitrogen is obvious from the
appearance of the peak at 1540 ern That the pyridine ring nitrogen is
protonated is confirmed by the single crystal x-ray studies done by
61
neutron-diffraction- studies by Bacon and
A peak at 405 em-lin the spectrum of pyridine has been assigned to
the out-of-p1ane ring deformation. In neutral pyridoxamine, pyridoxine
-1 -1
and pyridoxal, Figure 19, a strong peak occurs at 420 em ,415 em and
Figure 16. Infrared spectrum of pyridoxamine dihydroch1oride.
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Figure 17. Infrared spectrum of neu~ra1 pyridoxine.
A
100
2.5 3
I
4
I
5
I, • 1
6
I
". J~.
7
I
8
I, ,
9 10
:::1
:1",,1·
15 20 Jl 2~
, I l. I I I I I I 111111; I,II,I!
'l :. ~ ::I.. ;.... :.. :::::::.!
. : 1: :
... j . I .~ :_.-'il------j!I-------t-----t
';
'l.
-l
.\:: :\)
_.,_.~.-
:7=-===l-=:'
._--~--,--~--
..
.lV.
7-
\
20
40
80
60
2000
v
4000
In
\.0
Figure 18. Infrared spectrum of pyridoxine monohydroch1oride.
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-1395 cm , respectively. The peaks might correspond to the out-of-plane
ring deformatio~ bands for these compounds.
Infrared Spectra of the Complexes
PtCIZPM.HZO: The spectrum of PtClZPM.H20 is shown in Figure 20. The
-1
most noticeable feature is the appearance of a peak at about 1515 cm
There is no similar peak in the spectrum of neutral pyridoxamine. The peak
has been assigned to the vibration of the protonated pyridine ring nitrogen.
The appearance of such a band in pyridoxamine complexes has also been
observed ....1The band at 2080 cm in the spectrum of
neutral pyridoxamine (Fig. 15) which was assigned to the presence of a
protonated amine group -NH3+ is absent in the spectrum of PtClZPM.HZO
complex. The above two observations suggest that the proton on the amine
group -NH3+ is lost to the pyridine ring nitrogen atom. In other words,
complex formation involves a change in the tautomeric structure of
pyridoxamine. +The loss of the proton from the amine groups -NH3 is
reasonable since coordina1:-i~on of the amino group to the metal ion could
occur only if the amino group is neutral, that is, in the -NHZ form.
Similar observation has been made by Farago 49 With the -NHZ
coordinated the N-H stretching frequencies shift to lower values because
the N-H bond order is reduced. There are a number of medium-weak peaks
-1between 3500 and 3000 em in the spectrum of PtClZPM.HZO. These peaks
might be due to the N-H and O-H stretching frequencies. The band at
-13500 em could be" assigned to a stretching mode of lattice water. A
Figure Zo. Infrared spectrum of PtCIZPM.HZO.
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number of variations also occur in the region below 1500 cm-l The infrared
spectrum of K2PtC1,~ showed a Pt-C1 stretching frequency as a single very
strong band at 322 em-I. Between 600 cm-l and 200 cm-l in the spectrum of
PtC1ZPM.HZO, Figure 21a, a Pt-C1 stretching frequency could be assigned to
the sharp band at 342 em-I. There is a shoulder band at 334 cm~l which
indicates that the two chlorine atoms in PtC12PM.HZO are in the cis
-1· -1
configuration. There are two peaks at 400 em and 445 em which could
be assigned to Pt-O and Pt-N stretching vibrations, respectively. The
-1
spectrum of neutral pyridoxamine contains bands below the region 600 em
consequently the assignments are tentative and would be difficult to
confirm without the use of isotope studies. The observations made in the
preceding discussion of the infrared spectrum of PtC1ZPM.HZO agree well
with the structure obtained by single crystal x-ray studies previously
mentioned.
~dC12P~: Comparison of the spectrum of PdCIZPM, Figure 22, with the
spectrum of neutral pyridoxamine shows th'at the pyridine ring nitrogen is
-1protonated as indicated by the strong band at 1540 em As was observed
+ -1 .in the spectrum of PtClZPM.H20 (Fig. 20), the -NH3 band at Z080 em 1n
the spectrum of neutral pyridoxamine is absent also in the spectrum of
PdClZPM. This again means that the aminomethy1 group is coordinated to
the palladium through the nitrogen atom. Some peaks which are present in
the spectrum of neutral pyridoxamine have been shifted or completely lost
in the spectrum of PdC1ZPM complex. There is a great variation between
-1 -1600 em and ZOO em • The peaks in the spectrum of PdC12PM, Figure Zlb,
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Figure 21. -1Ir (600-200 em ) spectra of (a) PtCIZPM.HZO, (b) 2+· 2-PdCIZPM and (c) [P~lli2] [PdC14] .H20
Figure 22. Infrared spectrum of PdCIZPM.
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are very weak to absent. There is only a medium and broad peak at
about 328 cm-l which might be assigned to a Pd-Cl stretching frequency.
Since the complex contains two chlorine atoms, four coordination of planar
palladium complex could be achieved if pyridoxamine che1ates to the
palladium through the phenolateo~ygen and amino nitrogen atoms. This is
a well established observation in pyridoxamine complexes.
Chelation of the phenolate oxygen and the amino nitrogen atoms means
that the two chlorine atoms are cis to each other. The occurrence of
cis-Pd-CI bonds in a complex is easily identified by the appearance of two
absorption bands for the Pd-Cl bonds (sometimes it is a doublet and
sometimes one is a shoulder of the other)72 The broad nature of the Pd-Cl
-1band at 328 em makes it difficult for the shoulder band to be observed •
.....1The Pd-Cl frequency in KZPdCl4 appears as a very strong band at 334 cm •
The large reduction in intensity and the shift of the band might clearly
indicate that there is formation of a complex between Pd(II) and the
pyridoxamine ligand. According to Kieft and Nakamoto, 73, 74 the absorption
bands for metal-nitrogen Jstretching vibration in complexes of amino acid
derivatives with Pt(II) and Pd(II) have been assigned as weak-medium bands
-1 -1 -1
at 550 cm , near 440 em ,and in the region 585-510 cm
peaks at these regions in the spectrum of PdClZPM are so weak that it is
impossible to assign a Pd-N stretching frequency with certainty. For the
same reason, no peaks can be assigned to the Pd-O vibration in PdClZPM.
It is, however, reasonable to suggest that the structure of PdClZPM is
similar to that obtained for PtClZPM.HZO whose structure has been
determined by single crystal x-ray studies.
68
2+ . 2- 2+[PMHZ] [PdC14~20: The cation KPMH2] is a diprotonated
pyridoxamine. -1The ir spectrum, Figure 23, shows a peak at 1560 em and a
-1
weak peak at 2040 em • The two peaks indicate that the pyridine ring
nitrogen and the amino group are both protonated. There is no direct
metal-ligand bonding and therefore Pd-N and Pd~O stretching vibrations
are not expected in the spectrum of this compound. There is a Pd-C1
-1
stretching frequency at 325 em in the spectrum, Figure 21c, of the
complex. The structure of the compound could be envisaged as square planar
[PdC14 ]2- anion hydrogen bonded by CL ••R to the [PMH2 ]2+ cation.
t~ans-PdC1Q(PN)Q: Unlike the spectrum of neutral pyridoxamine,
Figure 17, the spectrum of tran?-PdCl2 (PN)2' Figure 24, contains a prominent
-1peak at 1558 em which indicates that the pyridine ring nitrogen atom is
coordinated. Gill aL 62 have observed that when the pyridine ring
nitrogen atom is coordinated to a metal, a weak band appears between
-1 -1 -11235 em and 1250 em • The appearance of a medium peak at 1240 em in
-1the spectrum of trans_.....PdC12 (PN) 2" together with the peak at 1558 em shows
that the pyridine nitrogetr>i's coordinated to the metal. The metal chlorine
-1
stretching frequency appears at 345 em as a strong single peak, Figure
25a, which suggests a trans structure for the complex. Coates and Parkin75
assigned a medium peak at 472 cm-1 for the Pd-N stretching in
trans-PdC12 (pyridine) 2. There are a number of bands between 400 cm-
l
and
-1600 em in the spectrum of trans ......PdCl2 (PN)2' but since the spectrum of
neutral pyridoxine contains bands in this range, it is difficult to assign
a Pd-N stretching with certainty. The information from the infrared
spectra tend to support the structure obtained by single crystal x-ray
studies.
Figure 23. 2+ 2....Infrared spectrum of [PHH2] [PdC14] ,H20,
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Figure 24. Infrared spectrum of tran~......PdC12(PN)2.
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cis-PdC12 (PN)Z: The spectrum of cis-PdC12 (PN)2' Figure 26, exhibits
-1 -1 -1 1peaks at 1562 cm and 1245 cm (compare with 1558 cm and 1240 cm-
respectively in trans-PdC12 (PN)2) indicating that the pyridine nitrogen is
coordinated. -1The Pd-Cl stretching frequency occurs at 352 cm with a
shoulder band at 335 cm (Fig. 25b), suggesting a cis_Pd-C1 configuration.
cis-PdC12 (PL)Z: The spectrum of cis-PdC12 (PL)2' Figure 27, compared
with the spectrum of neutral PL, Figure 12, shows that there is a change in
-1 -1the region above 1400 em • The very strong peak at 1540 cm in the
spectrum of neutral PL is not present in the spectrum of the complex.
-1Instead, there is a medium-weak peak at 1580 cm Since the pyridine
-1
nitrogen in neutral PL was protonated, the peak at 1580 cm in the spectrum
of cis-PdC12 (PL)2 might suggest that the pyridine nitrogen is coordinated
to an element other than hydrogen. Tn other words, the pyridine nitrogen
is coordinated to the metaL For cis-PdC12 (pyridine)2' Coates and Parkin
75
-1.. .-1
assigned a weak peak at 458 em and a medium peak at 446 em to the Pd-N
stretching frequency. The spectrum of cis-PdC12 (PL)2' Figure 28a, contains
-1 -1
a very weak band at aboue~-4~8 cm and probably a shoulder band at 455 em •
These bands might correspond to the Pd-N stretching frequencies. There is
no characteristic carbonyl stretching band. This indicates that the ligand
is still in the hemiacetal form. The three bands at 2100-2000 cm-1 in the
spectrum of neutral PL are absent in the spectrum of the complex. That is
expected since on coordination to the metal through the pyridine nitrogen
the dipolar nature of the ligand is destroyed. The peak at about 3410-
-13000 cm in the spectrum of the complex might be assigned to the O-H
Figure 26. Infrared spectrum of cis-PdC12 (PN)2-
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Figure 27. Infrared spectrum ofcis-PdC12 (PL)2
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Figure 28. Ir (600-200 em
(a)
spectra of (a) CiS-PdCl\;PL) 2 and (b)
... (b)
+ 2-[PLH ]2[PtC16 ] .H20.
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stretching frequency. The pep:Ks
76
-1below 1500 cm shows changes both in
x-ray studies.
intensity and in position as might be expected. There are two strong
bands of about equal intensity at 330 cm-1 and 358 cm-1 (Fig. 28a). These
might be assigned to the Pd-CI stretching frequencies. The two peaks
indicate a~is configuration. These bands compare well with those obtained
by Coates and Parkin25 who observed two strong bands at 342 cm-1 and 333
cm-
1 for the cis-Pd-C1 stretching frequency in cis-PdC12(pyridine)2.
[PLH+]2[PtC16]2-.H20 : The cation [PLH+] has the pyridine ring nitrogen
protonated as was observed in the structure determined by single crystal
-1 + 2-The peak at 1540 cm in the spectrum of [PLH ]2[PtC16] .H20
Figure 29, indicates that the pyridine nitrogen is protonated as expected.
The spectrum contains no carbonyl band, an indication that the [PLH+] cation
is also in the hemiacetal form. This also is in agreement with the structure
obtained by single crystal x......ray studies. There are bands between 3600 and
3100 cm-1 which might be assigned to O-H stretching frequencies. Much of
+ 2- -1the spectrum of [PLH ]2[PtC16] .H20 between 1500 em and below resemble
the spectrum of pyridoxa!~-mdnohydroch!oride. A strong band centered at
-1335 cm in the spectrum of the complex, Figure 28b, might be assigned to
the Pt-Cl stretching frequency.
Carbon-!3 nuclear magnetic resonance spectra
The ligands pyridoxamine, pyridoxine and pyridoxal show eight peaks
in their 13C nmr spectra with 1H decoup1ing. A complete assignment of the
k h b d b b f · k 76,77~78,79pea save een one y anum er 0 wor ers. The carbon-13
Figure 29. + 2-Infrared spectrum of [PLH ]2[PtC16 ] .H20.
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chemical shifts have been found to have strong pH dependence because of
protonation and deprotonation reactions. Table 7 shows the carbon-I3
chemical shifts in ppmdownfield from external Me4Si, as obtained in
DMSO-d6 (that is in this work) and in D20. The spectrum of pyridoxal was
difficult to obtain at neutral pH because of poor solubility in DMSO-d6 8
There are slight variations in the positions of the peaks which might be
due to difference in pH in DZO and DMSO-d6 at which the spectra were
d d Th ff f 1 1 · · 80 · h 1 ·brecor e. . e e ect 0 so ute-so vent lnteractlon mlg t a so contrlute
to the difference in the positions of the peaks. However, the spectra
obtained in DMSO-d6 follow the general pattern as that obtained in DZO.
Since the spectra of the complexes were also recorded in DMSO~d6t comparison
of the spectra of the free ligands with those of the complexes could serve
a good purpose of showing the effect of complexation on the chemical shifts
of the ligands.
The spectra of pyridoXine, tr~ns-PdCl2(PN)Z and cis-PdCIZ(PN)Z are
shown in Figures 30, 31 and 32 respectively. The t:rans-PdC12(PN)Z complex
shows a number of the peaks "as doublets, fiotably the C(6), C(l), C(3) and
C(5) atoms. The chemical shifts of the complexes are shown in Table 7.
The double peaks suggest that the ligands are in slightly different
environments.
The presence of the do~ble peaks in the spectrum of .tra~s-PdCl2(PN)2
might be attributed to (i) the partial isomerization of the complex to the
~i~ configuration in solutions, (ii) the presence of uncoordinated ~igand,
(iii) rotation about the Pd-N bond when in solution, resulting in the two
Figure 30. C.....13 nmr spectrum of pyridoxine
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Figure 31. C-13 nmr spectrum of ~rans-PdC12(PN)2
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Figure 32. C-13 nmr spectrum of cis-PdC12 (PN)2
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Table 7. C-13 chemical shifts (ppm) for the free ligands and complexes
C(5) C(4) C(3) C(2) C(l) C(6) C(8) C(7)
pyridoxine DMSO .....d6 131.43 134.19 138.91 149.93 146.09 19.19 56.81 58.94
D20 pH 6.8 126.70 136.40 139.45 160.85 145 30 16.70 57.25 59.85
pyridoxamine J)MSO-d6 129.03 132.13 137.43 153.32 145.43 18.56 58.98 36.70
D20 pH 7 124.65 137.00 133.50 164.05 146.10 16.50 60.30 37.85
l.
pyridoxal DMSO-d6
I 128.08 136.36 137.15 146.58 144.45 18.04 70.68 99.90
DZO pH 12.5 1Z7.30 134.95 80 162,20 153.35 19.70 67.65 100.70a
134.00
00
~rans-PdC12(PN)2 DMSO-d6 133.53 135.12 141.51 150.76 148.02 21.30 55.81 57.94
N
133.72 141.20 147.78 20.33
141.19
~is-PdC12(PN)2 DMSO-d6 133.78 135.18 141.57 150.70 148.02 21.37 55.75 57.9420.39
cis-PdC12 (PL)2 DMSO-d6 135.73 136.21 147.17 148.26 148.02 21,00 68.65 98.2320.15
PdC12PM DMSO-d6 132.99 134.14 135.60 160,38 148.14 19.54 58.73
Values in DZO were those obtained by Lapper ~ 77
a
obtained at pH 6.2 7
C-atom numbering is as· follows: ~ 7 = CH20H 1 CHO, CH2NH23 /OHl-IO/ 40 2
5 A6
N CH3
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ligands lying in different planes. Since evidence from the single crystal
x-ray studies and the infrared spectrum indicate that the complex is in
the trans configuration, the occurrence of the doublets of peaks might be
due to an isomerization process in solution from the t~ans to the cis
configuration. It is not understood why such rearrangement could take place.
It is also expected that if the t~ans-PdC12(PN)2 isomerised in solution to
form the cis-PdCI2 (PN)Z' then the 'spectrum should be the same as that
obtained for c~s-PdCl2(PN)2 The two spectra are different. It is
therefore unlikely that the isomerization does take place in solution, and
therefore the occurrence of the double peaks could not be due to the
presence of the cis isomer in solution. An uncoordinated ligand will be
present if the solvent, that is, DMSO-d6 displaces a pyridoxine ligand and
is itself coordinated to the metal. Such an observation51 has been made in
solutions where in higher concentration, DMSO-d6 competes with pyridoxine
or pyridoxamine for Mn(II). However, if such displacement reaction occurs,
then it is expected that the peak height of say the C(6) chemical shift
-~_. ~ >'
should vary with time. Studies done by Prof. J. S. Hartman with the
complex ~rans-PdC12(PN)2 did not show any variation of the peak heights with
time. It might perhaps be that the displacement reaction does occur
immediately the DMSO-d6 is added to the complex, and that the reaction goes
to completion before the spectrum is recorded. If the free ligand does
occur in solution, then it might be expected to have some of the chemical
shifts being the same as for the shifts obtained in the absence of the metal.
Since the chemical shifts of the complex are different from those of the
84
8
HOH2C
H
7
~ 340 2
~ 1
N
OH
6
CH 3
7 = CH20H, CHO I CH2NH2
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In PdClZPM, the largest ~Ci value is for the C(2) atom. This is in
contrast to values obtained for the pyridoxine and pyridoxal complexes
where the C(Z) atom showed little sensitivity. The large ~Ci value for the
C(Z) atom in PdCIZPM suggests that the phenolate oxygen is coordinated to
the metal. The value for the G(7) atom could not be obtained because the
peak occurs at the same position where the DMSO-d6 peaks occur. It is,
however, sufficient to conclude that in PdClZPM the ligand chelates the
metal atom through the phenolate oxygen and the amino nitrogen attached to
the G(7) atom. The values for C(5) and G(l) for PdCl2PM can not be left
unexplained. On chelation a proton is transferred from the amino nitrogen
to the pyridine nitrogen. The protonation of the ring nitrogen will create
a similar perturbation as occurred when the ring nitrogen coordinates to
the metal. Thus, C(5) and G(l) atoms will be deshielded. The magnitude of
the perturbation will, however, vary. Also, since the three ligands have
different tautomeric forms in solution, coordination to the metal will not
have the same magnitude of change in chemical shifts.
The 13C nmr spectrurrt-of PtCI2PM.H20 could not be obtained. After about
36 000 scans, the peaks could hardly be seen. It was therefore neglected.
The result is, however, not expected to be different from that of the
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CONCLUSION
Palladium and platinum complexes of pyridoxamine, pyridoxine and
pyridoxal have been prepared under various pH conditions. At neutral pH,
palladium and platinum reacted with pyridoxamine to produce the compounds
PdC12PM and PtCIZPJ:1. H20 respectively. In these products, the metal is
square planar and is chelated through the phenolate oxygen and the amino-
methyl nitrogen of pyridoxamine. The square planar coordination is
completed with the two chlorine atoms which are to each other. The
resulting product has the pyridine ring nitrogen of pyridoxamine protonated.
+ ' /
NH3 N~~M~
I
0- HO 0HO 0 0+ n+M-;f_·· ;. M= Pd(ll)
N N Pt(lI)1+
PYRIDOXAMINE (PM) H
In acidic medium, pH = 2, palladium reacted with pyridoxamine to form the
2+ 2-
salt [PMH2 ] [PdCl4 ] .H20.
Pyridoxine reacted with palladium at neutral pH and in slightly acidic
pH (pH = 6) to produce .tran?-PdCIZ(PN) 2 and cis-PdC12 (PN) 2 ' respectively.
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In both of these products, the pyridine nitrogen of pyridoxine is
coordinated to the metal which is square planar.
OH
OH
~OH(OH
OH HO \ ~OHO
+ Pd2+ :> /Pd
N \
PYRIDOXINE (PN) HO
OH
With pyridoxal t palladium formed the complex cis-PdCI2 (PL)Z at neutral pH.
The compound is similar to cis-PdCIZ(PN)2 in coordination. In acidic
medium, the reaction of platinum with pyridoxal resulted in the formation
+ Z-
of the salt [PLH ]2[PtC16] .ZHZO.
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